Stay updated with breaking news from Bioscience Segment. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com began coverage on shares of Grifols (NASDAQ:GRFS – Get Rating) in a report released on Thursday. The brokerage issued a hold rating on the biotechnology company’s stock. A number of other analysts also recently issued reports on the company. Morgan Stanley raised Grifols from an equal weight rating to an overweight rating in a […]
Grifols, S.A. (NASDAQ:GRFS – Get Rating)’s share price gapped down before the market opened on Wednesday . The stock had previously closed at $8.72, but opened at $8.53. Grifols shares last traded at $8.45, with a volume of 243,748 shares changing hands. Wall Street Analysts Forecast Growth GRFS has been the subject of several research […]
Moreno Evelyn V purchased a new stake in shares of Grifols, S.A. (NASDAQ:GRFS – Get Rating) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 13,869 shares of the biotechnology company’s stock, valued at approximately $118,000. Other institutional investors have also […]
Grifols, S.A. (NASDAQ:GRFS – Get Rating) gapped down prior to trading on Wednesday . The stock had previously closed at $7.39, but opened at $7.15. Grifols shares last traded at $7.21, with a volume of 181,980 shares. Analyst Ratings Changes A number of brokerages have issued reports on GRFS. Morgan Stanley raised Grifols from an […]
StockNews.com cut shares of Grifols (NASDAQ:GRFS – Get Rating) from a buy rating to a hold rating in a research note released on Wednesday. GRFS has been the topic of a number of other reports. Barclays upgraded Grifols from an underweight rating to an equal weight rating in a research note on Thursday, February 16th. […]